Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 - Marker Therapeutics, Inc. | mrkr-20201231xex32d2.htm |
EX-32.1 - EXHIBIT 32.1 - Marker Therapeutics, Inc. | mrkr-20201231xex32d1.htm |
EX-31.2 - EXHIBIT 31.2 - Marker Therapeutics, Inc. | mrkr-20201231xex31d2.htm |
EX-31.1 - EXHIBIT 31.1 - Marker Therapeutics, Inc. | mrkr-20201231xex31d1.htm |
EX-23.1 - EXHIBIT 23.1 - Marker Therapeutics, Inc. | mrkr-20201231xex23d1.htm |
10-K - 10-K - Marker Therapeutics, Inc. | mrkr-20201231x10k.htm |
Exhibit 21.1
SUBSIDIARIES
Marker Cell Therapy, Inc.
GeneMax Pharmaceuticals, Inc.
GeneMax Pharmaceuticals Canada, Inc.